Skip to main content
. 2022 Sep 22;39(4):1413–1431. doi: 10.1007/s10565-022-09767-5

Fig. 3.

Fig. 3

Treatment of CCL24 blocking antibody hindered angiotensin II–induced heart failure and cardiac hypertrophy. A M-mode echocardiography of left ventricular chamber and the measurement of ejection fraction (EF %) and fractional shortening (FS %). The data are represented as the means ± SEM (n = 16; one-way ANOVA; P < 0.05). B Hematoxylin and eosin staining of heart section. Scale bar in panel A is 1000 μm. C Representative heart size, and heart weight to body weight (HW/BW) ratio. The data are represented as the means ± SEM (n = 6; one-way ANOVA; P < 0.05). D TRITC-labelled wheat germ agglutinin staining of heart tissue sections, and quantification of cardiac-myocyte cross-sectional area (50 cells counted per heart). Scale bar in panel C is 50 μm. The data are represented as the means ± SEM (n = 6; one-way ANOVA; P < 0.0001)